HIV/AIDS Therapy
Tenofovir DF pharmacokinetics similar in children and adults
Published in AIDS Weekly, February 16th, 2004
Tenofovir DF "is a potent nucleotide analog reverse transcriptase inhibitor approved for the treatment of human immunodeficiency virus (HIV)-infected adults," scientists in the United States explained.
In a study conducted by R. Hazra and colleagues at the U.S. National Cancer Institute, "the single-dose and steady-state pharmacokinetics of tenofovir were evaluated following administration of tenofovir DF in treatment-experienced HIV-infected children requiring a change in antiretroviral therapy."
"Using increments of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-02-16)
More Articles from AIDS Weekly
- Drug Development
Fungal metabolite inhibits HIV integrase activity - Corporate Update
Biopharmaceutical company transformation completed - Drug Development
Mirror-image Zintevir analogue has similar anti-HIV activity - HIV/AIDS
In Mozambique, stigma remains obstacle to treatment for HIV+ women - HIV/AIDS Diagnostics
Three rapid immunoassays suitable for detection of non-B HIV subtypes - HIV/AIDS Drug Monitoring
LC/MS/MS assay enables ddI, d4T monitoring in wide range of specimen types - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
